跳至主要内容
临床试验/NL-OMON33433
NL-OMON33433已完成不适用

The AIM-to-OBserve study: Adipokines and Inflammatory Markers in childhood OBesity - AIMOB

niversitair Medisch Centrum Utrecht0 个研究点目标入组 140 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 17(—)

入选标准

  • Patientgroup:
  • 6-16 years of age
  • BMI (>30 kg/m2 projected at the age of18 years), according to international standards, see also Hirasing RA, Fredriks AM, van BS, Verloove-Vanhorick SP, Wit JM. [Increased prevalence of overweight and obesity in Dutch children, and the detection of overweight and obesity using international criteria and new reference diagrams]. Ned Tijdschr Geneeskd 2001 July 7;145(27):1303-8.;Controls:
  • Sex and age matched to patient group
  • -0.5 SD Newly referred patients to the pediatric outpatient department, by general practitioners, for the reason of:
  • - Suspected allergy or asthma
  • - Analysis of complaints of fatigue/malaise
  • - Prediction of final height
  • - Habitual constipation (i.e. constipation not explained by a disease)

排除标准

  • Patientgroup:
  • - Intoxication (smoking, i.e. sigaret use, drug-use)
  • - Acute illness (fever)
  • - Mental retardation
  • - Allergy with positive RAST for food/inhalation allergy and (history of) Muller class I-II reaction (i.e. severe systemic allergy/anaphylaxis)
  • - Asthma (based on doctors* diagnosis: history of recurrent wheezing, obstructive
  • lung function tests with reversibility after administration of β2-sympathicomimetics,
  • use of asthma-medication)
  • - Intoxication (smoking, drug-use)
  • - Acute illness (fever)
  • - Mental retardation
  • Exclusion criteria for involved referrals:
  • - Allergy with positive RAST for food/inhalation allergy and (history of) Muller class I-II reaction (i.e. severe systemic allergy/anaphylaxis)
  • - Asthma (based on doctors* diagnosis: history of recurrent wheezing, obstructive lung function tests with reversibility after administration of β2-sympathicomimetics, use of asthma-medication)
  • - Complaints of fatigue/malaise explained by M.Pfeiffer, inflammatory or infectious illness (e.g. inflammatory bowel disease, (viral) hepatitis, rheumatologic disease)
  • - Assessment of height when short or tall stature (height ± 1 SD of target height (TH), so height outside TH-range) or endocrine explanation for abnormal growth pattern (e.g. growth hormone deficiency)
  • The exclusion-criteria are formulated on the assumption that these might influence adipokine/inflammatory profiles.

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验